• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bone Biologics Corp - Common Stock (NQ:BBLG)

1.550 -0.020 (-1.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bone Biologics Corp - Common Stock

< Previous 1 2 Next >
News headline image
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
Today 8:00 EST
Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened balance sheet, and maintained Nasdaq compliance 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
December 23, 2025
Milestone advances manufacturing readiness and supports long-term commercialization strategy 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
September 04, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
September 03, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces Closing of $5.0 Million Public Offering
June 30, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Valuation, Nasdaq Compliance Etc. – More Stocks Inside
June 27, 2025
Via AB Newswire
Topics Regulatory Compliance
News headline image
Bone Biologics Announces Pricing of $5.0 Million Public Offering
June 27, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Files Patent Application for Bone Regeneration Technology
June 27, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
June 26, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces 1-for-6 Reverse Stock Split
June 06, 2025
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
October 21, 2024
From Bone Biologics
Via Business Wire
News headline image
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
August 02, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
June 21, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
June 20, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
June 18, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Bone Biologics Executives to be Interviewed in a “CEO Chat” by Zacks Small-Cap Research Analyst on June 20th
June 17, 2024
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Bone Biologics Announces Closing of $2.0 Million Public Offering
March 06, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces Pricing of $2.0 Million Public Offering
March 04, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Reports Progress With NB1 Clinical Program
March 01, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
January 11, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
January 10, 2024
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces 1-for-8 Reverse Stock Split
December 18, 2023
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2023
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 16, 2023
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device
September 26, 2023
From Bone Biologics
Via Business Wire
BioMedNewsBreaks – Bone Biologics Corporation (NASDAQ: BBLG) Announces $5M Underwritten Public Offering
June 21, 2023
Via Investor Brand Network
News headline image
Bone Biologics Prices $5.0 Million Underwritten Public Offering
June 14, 2023
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Effects 1-for-30 Reverse Stock Split
June 06, 2023
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
April 11, 2023
From Bone Biologics Corporation
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap